跳至主要内容
临床试验/NCT03806543
NCT03806543已完成不适用

The Influencing Factors of Vancomycin Trough Level and the Rate Achieving the Target Trough Level in Critically Ill Patients: A Retrospective Observational Study

Southeast University, China0 个研究点目标入组 165 人开始时间: 2015年1月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
165
主要终点
Rate of patients achieving the target vancomycin trough(15-20mg/L)

研究概览

简要总结

The aim of this study was to assess factors that may influence vancomycin trough level and the rate achieving the target trough level in critically ill patients.

详细描述

This retrospective observational study included adult patients treated with intravenous vancomycin in intensive care unit of Zhongda Hospital from January 2015 to December 2017. Vancomycin dose was based on international consensus and adjusted according to estimated glomerular filtration rate (eGFR) calculated by the Cockcroft-Gault equation. vancomycin trough level (VTL) was retained at steady state (after the third dose). Linear regression was performed to determine the correlation between factors prior to the first vancomycin dose and VTL. Distribution of VTL and percentage of patients achieving the target trough level (15-20mg/L) was observed in different renal function.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult ICU patients (age≥18 years) treated with intravenous vancomycin were included

排除标准

  • Chronic renal dysfunction and acute renal injury patients treated with Renal Replacement therapy
  • VTL was not retained at steady-state
  • Vancomycin treatment time≤48h
  • Vancomycin dose did not meet study definitions
  • Palliative care

结局指标

主要结局

Rate of patients achieving the target vancomycin trough(15-20mg/L)

时间窗: 3 years

Vancomycin trough level was retained at steady state (after the third dose). If a patient has multiple measurements of vancomycin trough level, the first measurement is collected.Rate of patients achieving the target trough level (15-20mg/L) was observed.

次要结局

未报告次要终点

研究者

发起方
Southeast University, China
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jingyuan,Xu

Principal Investigator

Southeast University, China

相似试验